Drospifem M 0,02 mg/3 mg filmom obložene tablete
| Name | Drospifem M 0,02 mg/3 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-652310924 |
| Active Substance | etinilestradiol drospirenon |
| Composition | svaka filmom obložena tableta sadrži 0,02 mg etinilestradiola i 3 mg drospirenona |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | mibe GmbH Arzneimittel, Brehna, Njemačka |
| Marketing Authorisation Holder | Mibe Pharmaceuticals d.o.o., Zavrtnica 17, Zagreb, Hrvatska |
| Marketing Authorisation Date | 13.12.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/28 |
| Registration Number | 381-12-01/171-22-07 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | G03AA12 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
